These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 582995)

  • 1. Pharmacokinetics and metabolism of taglutimide (K-2004) in the rat.
    Fiebrich F; Pischek G; Koch H
    Arzneimittelforschung; 1979; 29(7):1036-41. PubMed ID: 582995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of taglutimide, a new sedative-hypnotic drug.
    Schützenberger WG; Kolassa N; Wiener H; Kraupp O; Tuisl E
    Arzneimittelforschung; 1979; 29(8):1146-50. PubMed ID: 583013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative.
    Wiener H; Krivanek P; Tuisl E; Kolassa N
    Eur J Drug Metab Pharmacokinet; 1980; 5(2):93-7. PubMed ID: 6156838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
    Bechtel WD; Mierau J; Richter I; Stiasni M
    Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The biologic half-life of the thalidomide-like compound K-2004 (author's transl)].
    Pischek G; Koch H
    Arch Pharm (Weinheim); 1975 Nov; 308(11):863-8. PubMed ID: 1200808
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood level, excretion, and metabolite pattern of [14C]-brotizolam in humans.
    Bechtel WD; van Wayjen RG; van den Ende A
    Arzneimittelforschung; 1986 Mar; 36(3A):575-8. PubMed ID: 3718580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution, metabolism and excretion of etomidate, a short-acting hypnotic drug, in the rat. Comparative study of (R)-(+)-(--)-Etomidate.
    Heykants JJ; Meuldermans WE; Michiels LJ; Lewi PJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):113-29. PubMed ID: 1164098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in the disposition and metabolism of 1-methyl-3-(3-pyridyl)-5-(2-hydroxy-methylphenyl)-1H-1,2,4-triazole, a potential sedative-hypnotic compound.
    Assandri A; Omodei-Salè A; Ferrari P; Tuan G; Perazzi A; Ripamonti A; Martinelli E
    Xenobiotica; 1982 Jan; 12(1):19-30. PubMed ID: 7090416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic fate of supidimide in the rat.
    Becker R; Frankus E; Graudums I; Günzler WA; Helm FC; Flohé L
    Arzneimittelforschung; 1982; 32(9):1101-11. PubMed ID: 6890834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients.
    Luck C; Verho M; Umscheid T; Stelter WJ; Ziegler HP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S116-21. PubMed ID: 1725018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 1,4-dihydro-6-trifluoromethylquinoxaline-2,3-dione (Lilly 72525) in rats and cats.
    Page JG; Sullivan HR; Due SL
    Xenobiotica; 1976 Dec; 6(12):713-23. PubMed ID: 1007317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and excretion of a monoureide hypnotic, capuride.
    Johnson PC; Cressman WA; Driscoll TB
    Clin Pharmacol Ther; 1972; 13(3):377-9. PubMed ID: 4554661
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man.
    Noda K; Suzuki A; Okui M; Noguchi H; Nishiura M; Nishiura N
    Arzneimittelforschung; 1979; 29(10):1595-600. PubMed ID: 42414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the distribution and metabolism of neuroleptic drugs. II. Pharmacokinetics of moperone.
    Heykants JJ; Lewi PJ; Janssen PA
    Arzneimittelforschung; 1970 Sep; 20(9):1238-42. PubMed ID: 5536800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Absorption, elimination, and metabolism of K-2004 in man (author's transl)].
    Koch H; Pischek G; Hitzenberger G
    Arch Pharm (Weinheim); 1976 Aug; 309(8):609-18. PubMed ID: 971049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of Morocromen in animals and man (author's transl)].
    Dell HD; Jacobi H; Kamp R; Lorenz D
    Arzneimittelforschung; 1982; 32(5):492-8. PubMed ID: 7201825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.